FITC (FITC) antibody and antigen (hapten, BSA/OVA conjugated)

Diagnostic anti-FITC (FITC) antibodies (anti-FITC, anti-FITC) and diagnostic hapten-carrier conjugates BSA-FITC (FITC), OVA-FITC (FITC), KLH-FITC (FITC) antigens for Inflammation/autoimmune/inflammatory disease FITC detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-SMT-221-Ag01 BSA-FITC (FITC) 756
GMP-SMT-221-Ag02 OVA-FITC (FITC) 756
GMP-SMT-221-Ab01 Anti-human FITC (FITC) mouse monoclonal antibody (mAb) 1953
GMP-SMT-221-Ab02 Anti-human FITC (FITC) human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-SMT-221-Ag01
Product Name BSA-FITC (FITC)
Target/Biomarker FITC(FITC)
Expression platform Synthetic
Bioactivity validation FITC (FITC) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in FITC level test of Inflammation/autoimmune/inflammatory disease (NULL) and related syndrome evaluation.
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-FITC (FITC) / OVA-FITC (FITC) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-SMT-221-Ag02
Product Name OVA-FITC (FITC)
Target/Biomarker FITC(FITC)
Expression platform Synthetic
Bioactivity validation FITC (FITC) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in FITC level test of Inflammation/autoimmune/inflammatory disease (NULL) and related syndrome evaluation.
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-FITC (FITC) / OVA-FITC (FITC) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-SMT-221-Ab01
Product Name Anti-human FITC (FITC) mouse monoclonal antibody (mAb)
Target/Biomarker FITC(FITC)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Human FITC (FITC) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other FITC (FITC) antibodies in FITC level test of Inflammation/autoimmune/inflammatory disease (NULL) and related syndrome evaluation.
Tag mFc
Products description Anti-human FITC (FITC) monoclonal antibody (mAb) is a monoclonal antibody produced by hybridoma technology.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-SMT-221-Ab02
Product Name Anti-human FITC (FITC) human monoclonal antibody (mAb)
Target/Biomarker FITC(FITC)
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Human FITC (FITC) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other FITC (FITC) antibodies in FITC level test of Inflammation/autoimmune/inflammatory disease (NULL) and related syndrome evaluation.
Tag mFc
Products description Anti-human FITC (FITC) monoclonal antibody (mAb) is a monoclonal antibody produced by hybridoma technology.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    1. What is FITC, and what is its role in in vitro diagnosis (IVD)? Answer: Fluorescein Isothiocyanate (FITC) is a synthetic compound known for its remarkable fluorescent properties. In the realm of in vitro diagnosis (IVD), FITC is a linchpin that contributes significantly to the precision and sensitivity of diagnostic assays. Its utilization as a fluorescent probe and labeling agent has revolutionized the field of biomedical diagnostics. FITC operates as a fluorochrome by absorbing light at one wavelength and emitting light at a longer wavelength, resulting in a vivid and distinguishable fluorescence. This unique property makes FITC a pivotal component in various IVD applications. Its role primarily revolves around the development of highly specific and accurate diagnostic tests. In practice, FITC is conjugated to antibodies, antigens, or other biomolecules to create labeled probes that can selectively bind to specific target molecules within patient samples. These labeled probes act as beacons, enabling the detection and quantification of a wide range of analytes, including proteins, nucleic acids, and cellular structures. FITC is instrumental in various diagnostic techniques, such as enzyme-linked immunosorbent assays (ELISA), immunofluorescence assays, and flow cytometry. These tests are indispensable for diagnosing a myriad of medical conditions, including infectious diseases, autoimmune disorders, cancer, and more. FITC's presence in these assays ensures that they deliver precise and reliable results, crucial for clinical decision-making. Beyond diagnostics, FITC plays a pivotal role in advancing research endeavors. It is a key component in fluorescence microscopy, a powerful tool that allows scientists to visualize and study cellular and molecular structures with exceptional detail. This capability is vital for understanding disease mechanisms, conducting drug discovery research, and unraveling complex biological processes. 2. Why measure FITC? Answer: The measurement of FITC is essential in IVD for a multitude of compelling reasons, rooted in its unmatched performance and versatility. First and foremost, FITC-enhanced assays offer an unparalleled level of sensitivity and specificity. This precision is indispensable for the detection of minute quantities of target analytes, ensuring that diagnostic tests can reliably identify the presence of biomarkers associated with specific diseases. The ability to detect low concentrations of analytes is critical for early disease diagnosis, allowing for timely intervention and improved patient outcomes. FITC's reliability in delivering highly specific results makes it an ideal choice for the development of point-of-care testing (POCT) devices. These portable diagnostic tools provide rapid and accurate results at the patient's bedside or in remote settings, reducing the time to diagnosis and enabling prompt medical interventions. FITC's role in POCT is pivotal in improving healthcare access and ensuring that patients receive timely care. Furthermore, FITC aids in the development of novel diagnostic methodologies, contributing to the ongoing evolution of IVD. Researchers and clinicians continually explore innovative ways to leverage FITC's fluorescent properties to create advanced diagnostic platforms with improved performance and expanded capabilities. In summary, measuring FITC is not just a technical necessity; it is a driving force behind the advancement of IVD. Its unparalleled sensitivity, specificity, and versatility support the development of cutting-edge diagnostic tests, empower healthcare providers with reliable tools for disease diagnosis, and enable researchers to push the boundaries of medical science. FITC's presence in the biopharmaceutical industry underscores its pivotal role in delivering accurate and actionable diagnostic information, ultimately improving patient care and public health.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment